Top Stories
Latest Coverage
Global Counterfeit Drugs and CAR-T Scams: How Gray Market Channels Threaten Cancer Patient Safety
The issue of counterfeit drugs is no longer confined to traditional black markets; it has gradually infiltrated the c...
The issue of counterfeit drugs is no longer confined to traditional black markets; it has gradually infiltrated the c...
Counterfeit Cancer Drugs Seized Worldwide as WHO Issues Medical Product Alert
Recent coordinated law enforcement operations across multiple countries have uncovered large quantities of highly sop...
Recent coordinated law enforcement operations across multiple countries have uncovered large quantities of highly sop...
Lilly’s Triple Agonist Retatrutide Shows Promising Phase III Results: Up to 2% HbA1c Reduction and Nearly 17% Weight Loss
In recent years, GLP-1 receptor–based therapies have continued to reshape the global metabolic disease treatment land...
In recent years, GLP-1 receptor–based therapies have continued to reshape the global metabolic disease treatment land...
Counterfeit Cancer Drugs, Weight-Loss Medications, and ED Pills: The Growing Global Threat to Patient Safety
The global pharmaceutical industry has achieved remarkable breakthroughs over the last decade. From targeted oncology...
The global pharmaceutical industry has achieved remarkable breakthroughs over the last decade. From targeted oncology...
Eli Lilly’s Retatrutide Phase 3 Data Shocks the Market: Behind the 30% Weight Loss, the Peptide API Supply Chain Emerges as a New Hotspot
On May 21, Eli Lilly and Company announced positive topline results from the Phase 3 TRIUMPH-1 clinical trial of its ...
On May 21, Eli Lilly and Company announced positive topline results from the Phase 3 TRIUMPH-1 clinical trial of its ...
